Osteoclasts are multinucleated cells that differentiate from hematopoietic precursors 1) and possess characteristics to resorb mineralized bone. Osteoclast-like multinucleated cells (OCLs) can be differentiated in vitro from cocultures of mouse bone marrow cells and calvarial osteoblastic cells by treatment with osteotropic factors such as 1a,25-dihydroxyvitamin D 3 , prostaglandin E 2 , interleukin-1 (IL-1) or parathyroid hormone.
Osteoclasts are multinucleated cells that differentiate from hematopoietic precursors 1) and possess characteristics to resorb mineralized bone. Osteoclast-like multinucleated cells (OCLs) can be differentiated in vitro from cocultures of mouse bone marrow cells and calvarial osteoblastic cells by treatment with osteotropic factors such as 1a,25-dihydroxyvitamin D 3 , prostaglandin E 2 , interleukin-1 (IL-1) or parathyroid hormone. 2, 3) Osteoblasts or stromal cells are the target cells for these factors in bone. Recently, an essential factor provided by osteoblasts or stromal cells has been identified and named osteoclast differentiation factor (ODF)/osteoprotegerin ligand (OPGL)/tumor necrosis factor-related activation-induced cytokine (TRANCE)/receptor activator of nuclear factor-kB (NF-kB) ligand (RANKL). 4, 5) It has been shown that RANKL induces OCL formation in cultures of bone marrow cells in the presence of M-CSF without requiring osteoblasts or stromal cells. 6) RAW cells are also known to differentiate into osteoclasts in the presence of RANKL. 6) Several vegetables (onion, parsley, etc.) have attracted attention for their potential beneficial effects for the prevention of bone diseases such as postmenopausal osteoporosis. 7) Among them, onions have been shown to have the strongest properties to regulate bone metabolism 7) ; rats fed onions increased their bone mass. 8) Onion also inhibits bone resorption stimulated in ovariectomized rat, 9, 10) and an extract from onion is known to prevent tibial cortical and cancellous bone loss induced by a combination of low protein intake and diet-mediated mild hyperparathyroidism in rats. 11) Rutin (quercetin-3-O-glucose rhamnose) ( Fig. 1) has recently been reported to inhibit ovariectomy-stimulated bone resorption in rats. 12) These facts taken together suggest that rutin is one of the principal components of onions that effectively facilitate bone resorption, and that its inhibitory effect on bone loss could in part be responsible for its effects on increasing bone mass.
Quercetin (Fig. 1) is the major representative of the flavonoid subclass of flavonols commonly found in fruits and vegetables, 13, 14) and is also abundant in onion extracts (200-600 mg quercetin/kg onion) and primarily in the form of glycoside (rutin). 14) Dietary glycosides like rutin are thought to be converted into aglycone (like quercetin) in the large intestine by the glycosidase activity of intestinal bacteria. 15) While these facts suggest that quercetin inhibits bone resorption in animals, its target cells for bone resorption and its mode of action has not been fully elucidated. We investigated the effects of quercetin on the differentiation and activation of osteoclasts, and on bone resorption in cultures. We show here that quercetin inhibits pOC formation induced by sRANKL in cultures of mouse marrow-derived MD cells, and that it also inhibits bone resorption in organ cultures. Our results suggest that the inhibitory effect of quercetin both on differentiation and on actin ring formation in OCLs causes a suppressive effect on bone resorption.
Quercetin Suppresses Bone Resorption by Inhibiting the Differentiation and Activation of Osteoclasts

MATERIALS AND METHODS
Materials Six-to nine-week-old male Std.ddY mice were purchased from Japan SLC Co. (Hamamatsu, Japan). Quercetin (dissolved in dimethylsulfoxide or ethanol; final concentrations of DMSO and ethanol were 0.05% and less than 1%, respectively, and these concentrations did not affect the formation of osteoclast-like cells) and 1a, 25- Formation of Osteoclast-Like Cells from MD and RAW Cells Bone marrow cells were isolated from six-to nineweek-old male ddY mice as described previously. 16) Tibia and femora were aseptically removed and dissected free of adherent soft tissue. The bone ends were cut off and the marrow was forced out into a petri dish containing a-MEMϩ10% FBS. The marrow suspension was filtered with a fine mesh (about 100 mm) sieve to remove bone particles, then carefully agitated with a plastic Pasteur pipette to obtain a single-cell suspension. The bone marrow cells were washed twice, resuspended in a-MEMϩ10% FBS, and incubated for 24 h in M-CSF (5 ng/ml) at a density of 1ϫ10 6 cells/ml in 100 mm dishes. After 24 h, non-adherent cells were harvested, washed, and resuspended (1ϫ10 6 cells/ml) in a-MEMϩ10% FBS. These non-adherent cells were used as MD cells for osteoclast formation experiments. MD cells (1ϫ10 6 /ml) were added (100 ml/well) to 96-well plates. After 24 h, an additional 100 ml of a-MEMϩ10% FBS containing cytokines (M-CSF or sRANKL) was added to each well. The cells were then cultured for 1-3 d. RAW cells, which were supplied by the RIKEN Cell Bank (Tsukuba, Japan), were seeded to a 96-well plate (3ϫ10 3 cells/well). After 24 h, an additional 100 ml of medium containing sRANKL was added to each well. Osteoclast formation was evaluated by measuring TRAP activity in the fixed cells and by counting the number of TRAP-stained cells.
Localization of Tartrate-Resistant Acid Phosphatase (TRAP) After cell cultures, adherent cells were fixed in 10% formaldehyde for 10 min and then in a mixture of ethanol and acetone (1 : 1, v/v) for 1 min. Then they were stained for TRAP activity as previously described.
17) TRAPpositive mononuclear cells and TRAP-positive multinucleated cells (three or more nuclei) were counted under a microscope (IX70; Olympus).
TRAP Activity of the Culture Cells The cells were fixed with 10% formalin for 10 min and 95% ethanol for 1 min, and then dried. To measure TRAP activity, 100 ml citrate buffer (50 mM, pH 4.6) containing 10 mM tartrate and 5 mM p-nitrophenylphosphate was added to the dried cellcontaining wells. After incubation for 20-30 min, the enzyme reaction mixtures in the wells were transferred into another 96 well plate containing 100 ml of 0.1 N-NaOH. Absorption was measured at 410 nm with a microplate reader (Molecular Devices).
Viability Assay Cell viability was evaluated using a 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay. MD cells or RAW cells (1ϫ10 4 cells/well; 96-well plates) were cultured in the presence of quercetin for 24 h. After culture, cells were treated with MTT (a final conc.of 20 mg/ml) for 2 h, then precipitated dye was solubilized into dimethylsulfoxide, and the absorbance at 570 nm was measured.
Actin Ring Staining Actin rings of OCLs were detected by staining actin filaments with rhodamine-conjugated phalloidin. OCLs (about 200 cells/well) were formed from RAW cell cultures in the presence of sRANKL and PD 98059 (20 mM) (PD98059 is known to increase TRAP-(ϩ) cell formation induced by sRANKL in RAW 264.7 cell culture 18) ; thus, we used PD98059 to rapidly prepare a high number of mature OCLs with actin rings), and treated with quercetin for 24 h. At the end of incubation, OCLs were stained for TRAP activity for 30 min at room temperature. TRAP-positive OCLs were stained with rhodamine-conjugated phalloidin in the dark, and washed with cold phosphate-buffered saline (PBS). The distribution of actin rings of OCLs was visualized and detected under a fluorescence microscope.
Assay for Pit Formation The pit-forming activity of OCLs was determined by using a previously described modified method. 19) Briefly, crude OCL preparations, collected from ocultures of mouse spleen cells and ST2 cells on culture dishes precoated with 0.2% collagen gel matrix, were placed on 96-well plates containing dentine slices (4 mm in diameter) in the presence of quercetin for 24 h. After 24 h incubation, dentine slices were ultrasonicated in 1 M aqueous NH 4 OH to remove adherent cells. Resorption pits on the slice were stained with Mayer's hematoxylin solution. The number of pits was counted by microscopic observation.
Assay for 45 Ca Release from Long-Bone in Organ Culture System Pregnant ddY mice were injected sc with 25 mCi of 45 Ca (Amersham Pharmacia Biotech, Buckinghamshire, U.K.) on day 16 of gestation. Twenty-four hours after injection, radii and ulnae shafts were dissected from the fetuses, cleaned free of surrounding muscle and fibrous tissues, and precultured in serum-or BSA-free BGJb medium (Life Technologies, Grand Island, NY, U.S.A.). After 48 h preincubation, the bones were transferred into 0.5 ml BGJb medium containing 0.2% BSA and incubated for 72 h with or without quercetin in the presence of PTH (10 Ϫ7 M). At the end of the culture period, the bones were extracted in 0.1 N HCl. Radioactivity in media and bone extracts was determined by liquid scintillation spectrophotometry. Bone-resorbing activity was expressed as the percentage of the incorporated 45 Ca that was released into the medium. Figs. 2A, B-E) . The inhibitory effect of quercetin was in a dose-dependent manner. The quercetin concentration producing 50% inhibition was approximately 3 mM (Fig. 1A) , and quercetin 5 mM inhibited OCL formation by more than 90% (Figs. 2A, B) . To determine the effects of quercetin on OCL formation from osteoclast progenitor cells in the absence of osteoblasts, we used MD cells derived from bone marrow. As shown in Fig. 3 , sRANKL dramatically induced OCL formation in MD cell cultures for 4 d (Fig. 3A) . Quercetin inhibited OCL formation induced by sRANKL at 1-4 mM of concentration in a dose-dependent manner, and 4 mM quercetin inhibited OCL formation by about 90%. The IC 50 for the effects was approximately 1 mM (Fig. 3A) . However, as detected by MTT assay, MD cell viability was not affected by quercetin (Fig. 3B) . These results suggest that quercetin directly acts on osteoclast progenitors, and then inhibits OCL formation.
RESULTS
Quercetin Inhibits OCL Formation
Quercetin Inhibits TRAP Activity of pOC Cells Induced by sRANKL Next, we determined whether quercetin inhibits TRAP-(ϩ) preosteoclast (pOC) formation from osteoclast progenitors. sRANKL stimulated TRAP activity in the cultures of both MD cells (Fig. 3A) and RAW cells (Fig. 4) . TRAP-(ϩ) pOC cells were formed in the cultures of both MD cells (within 2 d treatment of sRANKL) 506 Vol. 27, No. 4 and RAW cells (within 3 d treatment of sRANKL), but no OCLs were formed in a two-day culture of MD cells or in three-day culture of RAW cells. Quercetin inhibited an increase of sRANKL-induced TRAP activity of pOC cells in both cell cultures (Figs. 4A, B) . The IC 50 for the effects of quercetin on the MD and RAW cells was approximately 1.5 and 2 mM, respectively. The effect of quercetin on the TRAP activity of pOC cells was consistent with that on OCL formation in MD cells and coculture. Quercetin did not affect the cell viability of RAW cells at 4 mM (data not shown), as judged from microscopic observation of the Dye-exclusion test using trypan blue. These results support the theory that quercetin acts directly on osteoclast progenitors.
Quercetin Induces the Disruption of Actin Rings in Mature Osteoclasts Actin ring formation in mature osteoclasts is essential to express bone resorption function. OCLs formed by the treatment of RAW cells with sRANKL readily form resorption pits on bone slices, 6) and PD 98059 stimulates OCL formation induced by sRANKL from RAW cells.
18) Therefore, we determined the effect of quercetin on the actin rings of mature OCLs, which were formed from RAW cells in the presence of sRANKL and PD 98059. Actin rings were visualized by staining actin with rhodamine-conjugated phalloidin. When OCLs with actin rings were treated with quercetin for 24 h, the size was constricted and the actin rings were disrupted (Fig. 5) . The disruptive effect of quercetin on actin rings was in a dose-dependent manner (Fig. 6B) . The quercetin concentration producing 50% disruption was approximately 5 mM, and when 10 mM quercetin was used, only about 10% of OCLs having actin rings remained. However, TRAP activity and the cell viability of OCLs was not significantly changed by quercetin (Figs.  6A, C) , and as judged from nuclear staining with Hoechst 33258, apoptotic OCLs, in which actin rings were disrupted, were not observed in the treatment of quercetin 10 mM for 12 h (data not shown). In addition, when quercetin was removed after 12 h treatment, the number of OCLs having actin rings was restored to 80% of the control cultures (24 h) (Fig.  6D) .
Quercetin Inhibits Bone Resorption To investigate the inhibitory effect of quercetin on bone resorption, we used both the pit formation assay and an organ culture system. Quercetin inhibited pit formation on dentine slices. 5 mM quercetin inhibited pit formation by about 40% (Fig. 7A) . The effect of quercetin on 45 Ca released from the bone into the medium was measured in organ cultures. PTH stimulated bone resorption in organ cultures, resulting in a release of previously-incorporated 45 Ca. PTH-stimulated 45 Ca release was inhibited by quercetin in a dose-dependent manner (2-10 mM) (Fig. 7B) , but basal 45 Ca release was not significantly affected (data not shown). The quercetin concentration producing 50% inhibition was approximately 5 mM. The suppressive effects of quercetin on bone resorption were correspondent to its disruptive effect on actin rings in OCLs.
DISCUSSION
Although quercetin is thought to inhibit bone resorption in animals, its target cells related to bone resorption and its mode of action have not been fully elucidated. We determined the effects of quercetin on the function and differentia- tion of osteoclasts. In this study we demonstrated that quercetin inhibits TRAP-(ϩ) pOC formation induced by sRANKL in cultures of MD and RAW cells, induces the disruption of actin rings in OCLs, and suppresses bone resorption in both pit assay and organ cultures. Our results indicate that the suppressive effect of quercetin on bone resorption might mainly result from its inhibitory effect on the early differentiation of osteoclast progenitor into pOC (Fig. 3) and its disruptive effect of actin rings in OCLs.
Onion extracts are known to prevent stimulated bone loss in animal experiments. [9] [10] [11] Recently it was demonstrated from OVX animal experiments that rutin is the main effective component of onion extract on bone resorption. 12) However, its target cells related to bone resorption have not been determined. Quercetin, one of the main flavonoid components, inhibited TRAP-(ϩ) pOC formation from both MD and RAW cell culture. We demonstrated the effect of quercetin on the early differentiation of osteoclasts from osteoclast progenitor cells, suggesting that they are one of the target cells of quercetin, and that its inhibitory effect on early differentiation is partially responsible for its suppressive effect on bone resorption in organ culture.
Recently, Wattel et al. reported that quercetin induces apoptosis in mature osteoclasts and inhibits bone resorption. 20) Although the IC 50 of quercetin on bone resorption is 5.3 mM, the ED 50 (effective dose) of quercetin on apoptosis in osteoclasts was more than 50 mM. 20) Thus, the quercetin-induced stimulation of apoptosis could partly explain its inhibitory effect on bone resorption. 20) In our study, 12 h treatment of 10 mM quercetin induced the disruption of actin rings (actin ring formation is an essential process in expressing bone resorption function) in OCLs by 80%, but TRAP activity and the cell viability of OCLs decreased by less than 15%. Furthermore, the removal of quercetin after 12 h treatment restored OCLs with actin rings by 80% of control cultures (24 h). These results indicated that quercetin-treated non-functional OCLs, where actin rings were disrupted, are still alive. The effective dose of quercetin for actin ring disruption was almost the same as that on bone resorption. These facts suggest that quercetin's inhibitory effect on pit formation results mainly from its disruptive effect on actin rings, although quercetin-induced apoptosis in OCLs may be partially involved in the suppression of bone resorption in the pit assay. Taken together, the inhibitory effects of quercetin on the early differentiation of osteoclast progenitors into pOC and actin ring formations in mature osteoclasts may explain its suppressive effect on bone resorption in organ cultures. Our findings also provide an explanation for quercetin's preventive effect on postmenopausal osteoporosis.
RANKL and M-CSF are two essential factors for pOC formation. MD cells, M-CSF-dependent cells derived from mouse bone marrow cells, are able to proliferate in the presence of M-CSF. Quercetin did not affect the proliferation mediated by M-CSF in MD cell cultures. Simultaneous treatment of MD cells with M-CSF and sRANKL induced the formation of pOCs; however, Quercetin inhibited pOC formation induced by RANKL from both MD and RAW cells. These results suggest that the inhibitory effect of quercetin on pOC formation is involved in the RANKL-mediated signaling pathway in both cell cultures. Extracellular signalingregulated kinase (ERK) kinase (MEK), p38 mitogen-activated protein kinase (MAPK) c-Jun N-terminal kinase (JNK) and NF-kappa B activation are involved in the RANKL-signaling pathway for osteoclastogenesis. [21] [22] [23] There are also several signal-transducing molecules related to actin ring formation in osteoclasts: p60 c-src tyrosine kinase, 24, 25) PI3K, 26, 27) GTP-binding proteins, 28, 29) and PKA. 30) Quercetin is known to inhibit the JNK pathway and protein tyrosine kinase. [31] [32] [33] These facts also suggest that quercetin may act on the signaling pathway involved in the formation of actin rings. Further study is necessary to better clarify the modes of action on both osteoclastogenesis and actin ring formation.
Quercetin, one of the most abundant flavonoids in the human diet, and its glucosides are present in high concentration in apples, broccoli, wine, and tea as well as in onions. 34) Quercetin is obtained from the daily intake of these foods. The plasma concentration of quercetin in human ranges from 0.5 mM to 1.6 mM, 35) correlats well with the concentrations that inhibit pOC formation. Thus, quercetin would be expected to inhibit bone resorption in human, and might be applicable for the prevention of bone diseases such as postmenopausal osteoporosis. At the end of culture period, bones were extracted in 0.1 N HCl. Bone-resorbing activity was expressed as the percentage of the incorporated 45 Ca that was released into the medium. Data are meansϮS.E. of results from three determinations. * , pϽ0.01 vs. control.
